VIA
EGRX

Vident Investment Advisory’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Vident Investment Advisory’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-19,314
Closed -$778K – 826
2018
Q4 		$778K Sell
19,314
-2,710
-12% -$109K 0.04% 474
2018
Q3 		$1.53M Buy
+22,024
New +$1.53M 0.06% 383